Literature DB >> 22064432

Arterial thrombosis--insidious, unpredictable and deadly.

Shaun P Jackson1.   

Abstract

The formation of blood clots--thrombosis--at sites of atherosclerotic plaque rupture is a major clinical problem despite ongoing improvements in antithrombotic therapy. Progress in identifying the pathogenic mechanisms regulating arterial thrombosis has led to the development of newer therapeutics, and there is general anticipation that these treatments will have greater efficacy and improved safety. However, major advances in this field require the identification of specific risk factors for arterial thrombosis in affected individuals and a rethink of the 'one size fits all' approach to antithrombotic therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22064432     DOI: 10.1038/nm.2515

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  164 in total

Review 1.  Cell signalling through thromboxane A2 receptors.

Authors:  Jin-Sheng Huang; Santosh K Ramamurthy; Xin Lin; Guy C Le Breton
Journal:  Cell Signal       Date:  2004-05       Impact factor: 4.315

Review 2.  LRP and PDGF signaling: a pathway to atherosclerosis.

Authors:  Philippe Boucher; Michael Gotthardt
Journal:  Trends Cardiovasc Med       Date:  2004-02       Impact factor: 6.677

3.  Platelet aggregation and thrombus formation in Diabetes Mellitus: an in vitro study.

Authors:  R L Rathbone; N G Ardlie; C J Schwartz
Journal:  Pathology       Date:  1970-10       Impact factor: 5.306

4.  Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets.

Authors:  J Jin; J L Daniel; S P Kunapuli
Journal:  J Biol Chem       Date:  1998-01-23       Impact factor: 5.157

5.  Factor XIIa inhibitor recombinant human albumin Infestin-4 abolishes occlusive arterial thrombus formation without affecting bleeding.

Authors:  Ina Hagedorn; Stefan Schmidbauer; Irina Pleines; Christoph Kleinschnitz; Ulrich Kronthaler; Guido Stoll; Gerhard Dickneite; Bernhard Nieswandt
Journal:  Circulation       Date:  2010-03-22       Impact factor: 29.690

6.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

7.  Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor.

Authors:  B Savage; E Saldívar; Z M Ruggeri
Journal:  Cell       Date:  1996-01-26       Impact factor: 41.582

Review 8.  New insights into the haemostatic function of platelets.

Authors:  Andrew H Wei; Simone M Schoenwaelder; Robert K Andrews; Shaun P Jackson
Journal:  Br J Haematol       Date:  2009-07-28       Impact factor: 6.998

9.  Platelet CD36 mediates interactions with endothelial cell-derived microparticles and contributes to thrombosis in mice.

Authors:  Arunima Ghosh; Wei Li; Maria Febbraio; Ricardo G Espinola; Keith R McCrae; Erin Cockrell; Roy L Silverstein
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

10.  Defective thrombus formation in mice lacking coagulation factor XII.

Authors:  Thomas Renné; Miroslava Pozgajová; Sabine Grüner; Kai Schuh; Hans-Ulrich Pauer; Peter Burfeind; David Gailani; Bernhard Nieswandt
Journal:  J Exp Med       Date:  2005-07-11       Impact factor: 14.307

View more
  188 in total

1.  Injury measurements improve interpretation of thrombus formation data in the cremaster arteriole laser-induced injury model of thrombosis.

Authors:  Steven P Grover; Pavan K Bendapudi; Moua Yang; Glenn Merrill-Skoloff; Vijay Govindarajan; Alexander Y Mitrophanov; Robert Flaumenhaft
Journal:  J Thromb Haemost       Date:  2020-10-29       Impact factor: 5.824

2.  CLEC-2 expression is maintained on activated platelets and on platelet microparticles.

Authors:  Eelo Gitz; Alice Y Pollitt; Jerney J Gitz-Francois; Osama Alshehri; Jun Mori; Samantha Montague; Gerard B Nash; Michael R Douglas; Elizabeth E Gardiner; Robert K Andrews; Christopher D Buckley; Paul Harrison; Steve P Watson
Journal:  Blood       Date:  2014-08-22       Impact factor: 22.113

3.  Platelet-RBC interaction mediated by FasL/FasR induces procoagulant activity important for thrombosis.

Authors:  Christoph Klatt; Irena Krüger; Saskia Zey; Kim-Jürgen Krott; Martina Spelleken; Nina Sarah Gowert; Alexander Oberhuber; Lena Pfaff; Wiebke Lückstädt; Kerstin Jurk; Martin Schaller; Hadi Al-Hasani; Jürgen Schrader; Steffen Massberg; Konstantin Stark; Hubert Schelzig; Malte Kelm; Margitta Elvers
Journal:  J Clin Invest       Date:  2018-08-13       Impact factor: 14.808

4.  Phospholipid-Coated Hydrophobic Mesoporous Silica Nanoparticles Enhance Thrombectomy by High-Intensity Focused Ultrasound with Low Production of Embolism-Inducing Clot Debris.

Authors:  Nicholas T Blum; Ciara M Gyorkos; Spencer J Narowetz; Evan N Mueller; Andrew P Goodwin
Journal:  ACS Appl Mater Interfaces       Date:  2019-09-26       Impact factor: 9.229

5.  Bad versus good cholesterol in the bone marrow.

Authors:  Eugene A Podrez
Journal:  Nat Med       Date:  2013-05       Impact factor: 53.440

Review 6.  Microvascular platforms for the study of platelet-vessel wall interactions.

Authors:  Ying Zheng; Junmei Chen; José A López
Journal:  Thromb Res       Date:  2014-01-07       Impact factor: 3.944

Review 7.  Systems biology of platelet-vessel wall interactions.

Authors:  Yolande Chen; Seth Joel Corey; Oleg V Kim; Mark S Alber
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

8.  Rate-limiting roles of the tenase complex of factors VIII and IX in platelet procoagulant activity and formation of platelet-fibrin thrombi under flow.

Authors:  Frauke Swieringa; Marijke J E Kuijpers; Moniek M E Lamers; Paola E J van der Meijden; Johan W M Heemskerk
Journal:  Haematologica       Date:  2015-03-13       Impact factor: 9.941

Review 9.  Thrombosis as an intravascular effector of innate immunity.

Authors:  Bernd Engelmann; Steffen Massberg
Journal:  Nat Rev Immunol       Date:  2012-12-07       Impact factor: 53.106

10.  Humanized GPIbα-von Willebrand factor interaction in the mouse.

Authors:  Sachiko Kanaji; Jennifer N Orje; Taisuke Kanaji; Yuichi Kamikubo; Yosuke Morodomi; Yunfeng Chen; Alessandro Zarpellon; Jerome Eberhardt; Stefano Forli; Scot A Fahs; Rashmi Sood; Sandra L Haberichter; Robert R Montgomery; Zaverio M Ruggeri
Journal:  Blood Adv       Date:  2018-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.